Molecular Imprint of Exposure to Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell Repertoire

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Smith, Corey ^a   Gras, Stephanie ^b   Brennan, Rebekah M ^a   Bird, Nicola L ^c   Valkenburg, Sophie A ^c   Twist, Kelly Anne ^b   Burrows, Jacqueline M ^a   Miles, John J ^a,g   Chambers, Daniel ^d,e   Bell, Scott ^d   Campbell, Scott ^f   Kedzierska, Katherine ^c   Burrows, Scott R ^a   Rossjohn, Jamie ^b,g   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d THE PRINCE CHARLES HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992736411     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03993     Document Type: Article

References (46)

1. Kenneson, A. & Cannon, M. J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17, 253-276 (2007).
2. Dollard, S. C., Grosse, S. D. & Ross, D. S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17, 355-363 (2007).
3. Crough, T. & Khanna, R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22, 76-98 (2009).
4. Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M. & Britt, W. J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344, 1366-1371 (2001).
5. Ross, S. A. et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 148, 332-336 (2006).
6. Mussi-Pinhata, M. M. et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 49, 522-528 (2009).
7. Yamamoto, A. Y. et al. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J 30, 1043-1046 (2011).
8. Ross, S. A. et al. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 201, 386-389 (2010).
9. Hughes, D. et al. Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients. J Clin Virol 41, 92-95 (2008).
10. Gorzer, I., Guelly, C., Trajanoski, S. & Puchhammer-Stockl, E. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol 84, 7195-7203 (2010).
11. Manuel, O. et al. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 49 (2009).
12. Bell, M. J. et al. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J Infect Dis 197, 1594-1597 (2008).
13. Khanna, R. et al. Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants. J Virol 70, 7306-7311 (1996).
14. Elkington, R. et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 77, 5226-5240 (2003).
15. Khan, N. et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 173, 7481-7489 (2004).
16. Reid, S. W. et al. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 184, 2279-2286 (1996).
17. Wang, G. C., Dash, P., McCullers, J. A., Doherty, P. C. & Thomas, P. G. T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection. Sci Transl Med 4, 128ra142 (2012).
18. Turner, S. J., Doherty, P. C., McCluskey, J. & Rossjohn, J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 6, 883-894 (2006).
19. Miles, J. J., Douek, D. C. & Price, D. A. Bias in the alphabeta T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 89, 375-387 (2011).
20. Gras, S. et al. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Immunol Rev 250, 61-81 (2012).
21. Theodossis, A. et al. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci U S A 107, 5534-5539 (2010).
22. Crough, T. et al. Symptomatic and asymptomatic viral recrudescence in solidorgan transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response. J Virol 81, 11538-11542 (2007).
23. Kumar, D. et al. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant 9, 1214-1222 (2009).
24. Khan, N. et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169, 1984-1992 (2002).
25. Trautmann, L. et al. Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. J Immunol 175, 6123-6132 (2005).
26. Gorzer, I., Kerschner, H., Redlberger-Fritz, M. & Puchhammer-Stockl, E. Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J Clin Virol 48, 100-103 (2010).
27. Prod'homme, V., Retiere, C., Imbert-Marcille, B. M., Bonneville, M. & Hallet, M. M. Modulation of HLA-A∗0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus. J Immunol 170, 2030-2036 (2003).
28. Prod'homme, V., Retiere, C., Valtcheva, R., Bonneville, M. & Hallet, M. M. Cross-reactivity of HLA-B∗1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein. J Virol 77, 7139-7142 (2003).
29. Meyer-Konig, U., Ebert, K., Schrage, B., Pollak, S. & Hufert, F. T. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352, 1280-1281 (1998).
30. Klarenbeek, P. L. et al. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog 8, e1002889 (2012).
31. Ladell, K. et al. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38, 425-436 (2013).
32. Chen, H. et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol 13, 691-700 (2012).
33. Miles, J. J. et al. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J Immunol 177, 6804-6814 (2006).
34. Turner, S. J. et al. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol 6, 382-389 (2005).
35. Tynan, F. E. et al. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 6, 1114-1122 (2005).
36. Burrows, S. R. et al. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci U S A 107, 10608-10613 (2010).
37. Macdonald, W. A. et al. T cell allorecognition via molecular mimicry. Immunity 31, 897-908 (2009).
38. Tynan, F. E. et al. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 202, 1249-1260 (2005).
39. Tynan, F. E. et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 8, 268-276 (2007).
40. Archbold, J. K. et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med 206, 209-219 (2009).
41. Brochet, X., Lefranc, M. P. & Giudicelli, V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36, W503-508 (2008).
42. Kjer-Nielsen, L. et al. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J Immunol 169, 5153-5160 (2002).
43. Kabsch, W. Xds. Acta Crystallogr D Biol Crystallogr 66, 125-132 (2010).
44. McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658-674 (2007).
45. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132 (2004).
46. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221 (2010).